相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
Christian M. Zechmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
A Prospective Pilot Study of 89Zr-J591/Prostate Specific Membrane Antigen Positron Emission Tomography in Men with Localized Prostate Cancer Undergoing Radical Prostatectomy
Joseph R. Osborne et al.
JOURNAL OF UROLOGY (2014)
Noninvasive Imaging of PSMA in Prostate Tumors with 89Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives
Nerissa Therese Viola-Villegas et al.
MOLECULAR PHARMACEUTICS (2014)
The prostate-specific membrane antigen: Lessons and current clinical implications from 20 years of research
Benjamin T. Ristau et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Cloning and characterization of canine prostate-specific membrane antigen
Sonja Schmidt et al.
PROSTATE (2013)
Prostate-specific membrane antigen-based imaging
Joseph R. Osborne et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?
Frederic E. Lecouvet et al.
EUROPEAN UROLOGY (2012)
International Variation in Prostate Cancer Incidence and Mortality Rates
Melissa M. Center et al.
EUROPEAN UROLOGY (2012)
Imaging-Based Tumor Treatment Response Evaluation: Review of Conventional, New, and Emerging Concepts
Hee Kang et al.
KOREAN JOURNAL OF RADIOLOGY (2012)
Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men
Maurice Anidjar et al.
PROSTATE (2012)
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature
G. Bauman et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2012)
Functional Imaging for Prostate Cancer: Therapeutic Implications
Carina Mari Aparici et al.
SEMINARS IN NUCLEAR MEDICINE (2012)
Prostate Cancer: Multiparametric MR Imaging for Detection, Localization, and Staging
Caroline M. A. Hoeks et al.
RADIOLOGY (2011)
Non-FDG PET in the practice of oncology
P. Caroli et al.
INDIAN JOURNAL OF CANCER (2010)
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
Jason P. Holland et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
Shawn M. Hillier et al.
CANCER RESEARCH (2009)
The Fer Tyrosine Kinase Cooperates with Interleukin-6 to Activate Signal Transducer and Activator of Transcription 3 and Promote Human Prostate Cancer Cell Growth
Amina Zoubeidi et al.
MOLECULAR CANCER RESEARCH (2009)
Botulinum Toxin Type A Inhibits the Growth of LNCaP Human Prostate Cancer Cells InVitro and InVivo
Gilles Karsenty et al.
PROSTATE (2009)
Prostate cancer in dogs: Comparative and clinical aspects
Bruce E. LeRoy et al.
VETERINARY JOURNAL (2009)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
Preparation and characterization of new anti-PSMA monoclonal antibodies with potential clinical use
Serge Moffett et al.
HYBRIDOMA (2007)
Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique
P. Mhawech-Fauceglia et al.
HISTOPATHOLOGY (2007)
The University of California, San Francisco cancer of the prostate risk assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy
MR Cooperberg et al.
JOURNAL OF UROLOGY (2005)
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
N Schülke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer
AV D'Amico et al.
CANCER (2002)
Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer
AV D'Amico et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
分享论文
